Latest updates for Impella Heart Pump

Fresh curated links around Impella heart pump are collected here so marketers can spot useful updates and turn timely ideas into posts faster.

Recent items include:

  • How did we fall for the newer MCS devices in cardiogenic shock ? A call for continued, “Guilt-free” usage of IABP
  • FDA issues early alert for J&J’s Abiomed catheter introducer over manufacturing issues, bleeding risk
  • How good is Heart mate- 3. as destination therapy in end stage HF . Can it reach Heart transplantation survival rates ?

Post angles to try

Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Turn angles into scheduled posts

Fresh articles and ideas

Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.

drsvenkatesan.com /1 month ago

How did we fall for the newer MCS devices in cardiogenic shock ? A call for continued, “Guilt-free” usage of IABP

The rise of percutaneous mechanical circulatory support (MCS) in cardiogenic shock is phenomenal. Reason : It is a blind assumption that newer and powerful intra /extra cardiac dev...

Read source
fiercebiotech.com /3 weeks ago

FDA issues early alert for J&J’s Abiomed catheter introducer over manufacturing issues, bleeding risk

The FDA has sent out an early alert to J&J’s Abiomed unit and its manufacturing partner, Oscor, for their catheter introducer kits that are used with Impella heart pumps amid m...

Read source
drsvenkatesan.com /1 month ago

How good is Heart mate- 3. as destination therapy in end stage HF . Can it reach Heart transplantation survival rates ?

The primary treatment for end-stage heart failure is heart transplantation, but due to organ shortage and the poor progress in our pursuit for total artificial hearts, LV assist de...

Read source
japantimes.co.jp /1 month ago

Japan startup tests catheter injection of iPS heart muscle cells

The Tokyo-based company hopes to develop a minimally invasive treatment method that does not require surgery.

Read source
emdocs.net /1 month ago

Update on LVADs in the ED: Presentations, Evaluation, and Management

What's new with LVADs? The post Update on LVADs in the ED: Presentations, Evaluation, and Management appeared first on emDocs.

Read source
www3.nhk.or.jp /1 month ago

iPS細胞使う心臓病治療の治験1例目を実施 カテーテルで移植

iPS細胞から作った心臓の細胞をカテーテルを使って心臓病の患者に移植する治験の1例目を行ったと、慶応大学発のベンチャー企業などが発表しました。胸を開く手術を行う必要がなく、企業は患者の...

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.

Sources covering Impella Heart Pump

emdocs.net

Recent coverage from public sources
Public source

www3.nhk.or.jp

Recent coverage from public sources
Public source

drsvenkatesan.com

Recent coverage from public sources
Public source

fiercebiotech.com

Recent coverage from public sources
Public source

japantimes.co.jp

Recent coverage from public sources
Public source